Stay updated with breaking news from Davidm kurtz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tessa Therapeutics Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial of Autologous CD30.CAR-T Therapy (TT11) in Relapsed or Refractory Classical Hodgkin Lymphoma
GlobeNewswire
December 12, 2022
Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate a 73.3% overall response rate and 60% complete. ....
PhasED-Seq ctDNA detection enables accurate and predictive treatment response monitoring and clinical prognosis in patients with B-cell lymphoma.A. ....
/PRNewswire/ Foresight Diagnostics, a leader in minimal residual disease (MRD) detection technology, announced today that three studies utilizing their. ....
New data from clinical trials of TT11 and TT11X to be featured in two oral podium presentations and a poster presentationSINGAPORE, Nov. 03, 2022 (Tessa), a clinical-stage cell therapy company developing ....
Yale community logs into 'For Humanity' campaign launch – India Education | Latest Education News | Global Educational News indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.